Loading...
Market
Will CVS meet or exceed its adjusted EPS estimate for Q4 2024?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
CVS Health Q4 2024 earnings report
Story
CVS Names David Joyner CEO as Shares Plunge 13% on Lower Earnings and Withdrawn Outlook
Oct 18, 2024, 10:45 AM
CVS Health has appointed David Joyner as its new Chief Executive Officer, replacing Karen Lynch, who stepped down after an agreement with the board. The company is backing away from its most recent 2024 outlook issued in August, as it grapples with lower-than-expected earnings. CVS announced that its preliminary third-quarter adjusted earnings per share are expected to be between $1.05 and $1.10, significantly below analysts' estimates of $1.70. The healthcare giant also cited higher medical cost trends, with a medical loss ratio of 95% compared to expectations of 91%. Following the news, CVS shares have plunged by over 13% in pre-market trading.
View original story
Similar markets
Below $1.00 • 25%
$1.00 to $1.50 • 25%
Above $1.50 • 25%
Other • 25%
Revenue increases • 25%
Revenue decreases • 25%
Net income increases • 25%
Net income decreases • 25%
Outperforms Walgreens • 25%
Underperforms Walgreens • 25%
Outperforms Cigna • 25%
Underperforms Cigna • 25%
Less than $90 billion • 25%
$90 billion to $95 billion • 25%
$95 billion to $100 billion • 25%
More than $100 billion • 25%
